| 1 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
The STEM-PD project focuses on developing a stem cell-based therapy for Parkinson's Disease. To ensure the treatment is safe and effective, the "purity" of the batch is assessed by checking for the presence of specific dopaminergic progenitor markers. FOXA2 and OTX2 are the primary markers used to define the identity and purity of these cells. A high percentage of cells (typically
) must express both markers for the batch to be considered successful. Other markers like SOX1 and PAX6 are monitored to ensure they are absent, as they indicate "off-target" or incorrect cell types. |
The quality control (QC) criteria for STEM-PD are based on research published regarding the clinical-grade manufacturing of human embryonic stem cell-derived dopaminergic progenitors. The theory relies on Flow Cytometry analysis to quantify protein expression. According to clinical trial protocols (such as those from Lund University), the co-expression of FOXA2/OTX2 confirms that the cells have correctly differentiated into the ventral midbrain identity required to treat Parkinson's, while the absence of PAX6/SOX1 rules out contamination with non-mesencephalic neural cells. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
The primary goal of integrating AI into medical imaging is to serve as a powerful clinical decision support tool. While AI can assist in administrative tasks or research, its most significant impact is its ability to analyze complex image data (like X-rays, CT scans, and MRIs) with high precision. It helps radiologists identify abnormalities, such as early-stage tumors or small fractures, that might be missed by the human eye. This leads to faster, more accurate diagnoses, allowing for timely treatment and ultimately saving lives. |
The application of AI in this field is rooted in Pattern Recognition and Deep Learning (specifically Convolutional Neural Networks or CNNs). These technologies are modeled after the human visual cortex to process and interpret visual data. Research published in journals such as The Lancet Digital Health and Radiology demonstrates that AI algorithms can achieve performance levels comparable to, or in some cases exceeding, human experts in specific diagnostic tasks. This is supported by the principle of Evidence-Based Medicine (EBM), where AI provides data-driven insights to optimize clinical outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI acts as a digital assistant that provides a "second set of eyes." It helps radiologists identify subtle abnormalities, such as small tumors or fractures, that might be overlooked due to fatigue or high workloads. This enhances diagnostic accuracy and provides a safety net for clinical decisions. |
According to various medical journals (such as The Lancet Digital Health or Radiology), the primary clinical application of AI is Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx). These systems are designed to supplement human expertise by reducing false negatives and improving the overall sensitivity of medical imaging analysis. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to various definitions in educational and technological articles, AI literacy refers to a comprehensive set of competencies that includes the knowledge and understanding of how artificial intelligence works. This literacy empowers individuals to critically evaluate AI systems, understand their capabilities and limitations, and use these tools effectively and ethically in various settings. While specific articles may vary slightly in focus, the recurring foundational theme is the broad understanding and practical knowledge of AI technology rather than just technical skills like repairing machines or deep legal knowledge. |
The core definition is Long and Magerko. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Acceptance of medical technology is based on functional, ethical, and professional factors. While trust, workflow integration, and understanding of the system are critical for clinical safety and efficiency, the physical aesthetic (such as the color of the machine) does not impact a professional's decision to adopt a medical tool. |
The UTAUT model suggests that technology adoption is driven by Performance Expectancy (usefulness), Effort Expectancy (ease of use), Social Influence, and Facilitating Conditions. Factors like "System Understanding" and "Workflow Integration" fall under these categories, whereas "The Color of Machines" is irrelevant to the utility or ease of use in a professional context. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence reflects the extent to which an individual perceives that "important others" (such as colleagues, supervisors, or the medical community) believe they should use the new system. In a healthcare context, professionals often rely on the consensus and norms of their peers to validate the reliability and professional safety of using AI, which directly shapes their decision to adopt it. |
The Unified Theory of Acceptance and Use of Technology (UTAUT). This theory identifies Social Influence as one of the key constructs that determine a user's behavioral intention to use a technology. It suggests that individuals are more likely to accept a new system if they perceive that people who are important to them think they should use it. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
One of the most significant psychological and professional concerns among medical staff is job displacement. There is a fear that AI’s ability to analyze data and diagnose conditions more accurately or faster than humans could lead to the reduction of human roles or the complete replacement of certain medical professions. |
This concept is often discussed in the context of "Technological Unemployment" and the "Dehumanization of Healthcare." Research published in journals like The Lancet Digital Health or Journal of Medical Internet Research (JMIR) frequently highlights that while AI is intended to be a tool for augmentation, the "Human-in-the-loop" principle is often perceived to be at risk, leading to professional identity threats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
AI must align with the professional values and clinical practices of medical experts. It's not just about speed, but about how it supports the doctor-patient relationship.Designing with a human focus ensures the AI fits into the daily workflow of a busy hospital without adding unnecessary complexity, which builds trust. |
Human-Centred Design (HCD) / Human-Centred AI (HCAI):
This theory emphasizes that technology should be designed based on user needs, human psychology, and ethical considerations. In healthcare, HCAI moves beyond "algorithmic performance" (how well the code works) to "sociotechnical integration" . |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
The 'system usage' category focuses on how a technology practically fits into a professional environment. Value proposition (the benefit it provides) and workflow integration (how easily it fits into daily tasks) are the core elements that determine whether a system will actually be used by healthcare professionals. Other options, like personal preferences or insurance, do not directly relate to the practical utility and functional fit of the AI system itself. |
This concept is rooted in the Technology Acceptance Model (TAM) and its adaptations for healthcare (such as UTAUT). These theories suggest that Perceived Usefulness (value proposition) and Perceived Ease of Use (integration with workflows) are the primary drivers of technology adoption. In medical AI research, "System Usage" specifically evaluates if the AI reduces the user's burden and enhances their current work efficiency. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Healthcare professionals are bound by strict ethical codes. They are more likely to accept AI when it aligns with their professional duties, such as ensuring patient safety and providing high-quality care. If AI is seen as biased or untrustworthy, it conflicts with these values, leading to low acceptability. |
The Four Principles of Biomedical Ethics (Beauchamp and Childress): This framework includes Beneficence (acting in the patient's best interest), Non-maleficence (do no harm), Autonomy (respecting patient choice), and Justice (fairness). AI acceptability depends on how well the technology supports these four pillars. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Modern AI research has shifted from purely technical performance (like speed or cost) to a holistic approach. Success is now measured by how well the AI fits into a user's daily life and professional workflow. Deeply considering User Experience (UX) ensures the system is trustworthy and easy to use, while System Integration ensures it works harmoniously within existing organizational structures, which is critical for long-term adoption. |
Technology Acceptance Model (TAM): Focuses on "Perceived Usefulness" and "Perceived Ease of Use" as primary drivers of technology adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The use of stem cells is a regenerative approach rather than just managing symptoms. By producing new, healthy dopamine-releasing neurons, this therapy aims to restore the brain's ability to produce dopamine naturally. |
The theoretical basis relies on the pluripotency of embryonic stem cells, which allows them to become any cell type, including midbrain dopaminergic neurons, when exposed to specific signals. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
Preclinical studies for the STEM-PD product, which is a stem cell-based therapy for Parkinson's disease, extensively used rat models to establish both safety and efficacy before proceeding to human clinical trials. A 39-week study was conducted under Good Laboratory Practice (GLP) using immunodeficient nude rats to ensure the product did not cause toxicity, tumor formation (tumorigenicity), or spread to unintended areas (biodistribution). |
Kirkeby, A., et al. (2023). "Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease: STEM-PD." Cell Stem Cell. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
This duration is selected because it is the standard requirement for chronic toxicity studies in rodents for drugs intended for long-term clinical use (more than 6 months in humans), as specified in international regulatory guidelines. |
According to the ICH M3(R2) guideline (Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals), the recommended duration for chronic toxicity studies in rodents (rats) is typically 6 months. This timeframe allows researchers to evaluate potential cumulative organ toxicity and long-term safety before or during extensive human clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
STEM-PD is a "first-in-human" trial. This specific combined phase is designed to primary evaluate the safety and tolerability of the treatment (Phase I) while also gathering early data on its effectiveness and optimal dosage (Phase IIa) in a small group of patients. |
The trial is based on Cell Replacement Therapy. In Parkinson's disease, dopamine-producing neurons are lost. STEM-PD uses human embryonic stem cells (hESCs) to create new dopaminergic neurons, which are then transplanted into the brain to restore function.
References: Clinical protocols (e.g., NCT05635409) and peer-reviewed journals such as Cell Stem Cell describe the preclinical safety and the design of this Phase I/IIa study. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is a cell-based therapy for Parkinson's Disease. For use in human clinical trials, it must be produced in a highly controlled environment to ensure safety, purity, and consistency. Therefore, it is manufactured under Good Manufacturing Practice (GMP) compliant conditions. The process involves a 20-day directed differentiation protocol to turn stem cells into dopamine-producing nerve cells, followed by rigorous quality control. |
According to clinical research and manufacturing protocols (such as those published regarding the STEM-PD clinical trial), human embryonic stem cell (hESC)-derived products must adhere to Advanced Therapy Medicinal Products (ATMP) regulations. These regulations require manufacturing to be performed in GMP-certified facilities to guarantee that each batch meets predefined standards for identity, potency, and sterility, which is essential for regulatory approval by bodies like the MHRA or EMA. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
Preclinical safety studies conducted under Good Laboratory Practice (GLP) standards showed that the STEM-PD cells remained at the site of injection without spreading to other organs and, most importantly, did not cause any toxic reactions or tumor growth (teratomas) over a long-term observation period of 9 months. |
The safety assessment is based on Preclinical Toxicology and Biodistribution studies. In regenerative medicine, a primary safety concern for stem-cell-derived products is tumorigenicity (the potential to form tumors). The STEM-PD product uses differentiated dopamine progenitor cells, which, unlike undifferentiated stem cells, have a significantly lower risk of forming tumors. The study's results showed no "adverse events," confirming its safety profile for moving into human clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The study aimed to evaluate whether STEM-PD (human embryonic stem cell-derived dopaminergic progenitors) could restore function in Parkinson’s Disease models. The results showed that the transplanted cells successfully matured into dopamine neurons and integrated into the brain, leading to a significant improvement and reversal of motor deficits in the rats. |
The primary reference is the preclinical data published regarding the STEM-PD product. Research published in journals such as Cell Stem Cell (e.g., studies by Kirkeby et al.) demonstrates that hESC-derived midbrain dopaminergic neurons can achieve long-term survival, re-innervate the striatum, and mediate functional recovery in 6-OHDA-lesioned rat models. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
in the production of STEM-PD (a stem cell therapy for Parkinson's disease), the goal is to create specific midbrain dopaminergic neurons. FGF8b and SHH act as biological signals that tell the stem cells exactly what kind of neuron to become, ensuring the cells develop into the correct functional type needed for treatment. |
This process is based on the principle of "Directed Differentiation" or "Developmental Mimicry." In developmental biology, Sonic Hedgehog (SHH) and Fibroblast Growth Factor 8 (FGF8) are morphogens responsible for patterning the ventral midbrain. By mimicking these natural embryonic signals in a lab setting (in vitro), scientists can precisely guide pluripotent stem cells to differentiate into ventral midbrain (VM) dopaminergic progenitors, which are the therapeutic components of STEM-PD. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The primary goal of many preclinical efficacy trials, especially those involving neurological conditions like spinal cord injuries or strokes, is to determine if a treatment helps restore lost physical abilities. Recovery of motor function is a direct, observable, and quantifiable indicator that the therapy is working at a functional level. Unlike "Increase in Lifespan," which is more common in toxicity or aging studies, motor recovery specifically demonstrates therapeutic efficacy in repairing or bypassing damaged neural pathways. |
In neurorehabilitation and regenerative medicine research, the Basso, Beattie, and Bresnahan (BBB) Locomotor Rating Scale is a widely recognized standard (reference: Basso et al., 1995). This theory/scale is used to evaluate the recovery of hindlimb function in rats. The principle is that behavioral recovery serves as the most critical "endpoint" for preclinical success, reflecting the integration of cellular repair and neural plasticity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|